Seif Al-Abri
Overview
Explore the profile of Seif Al-Abri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
691
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Rawahi B, Patel P, Al-Farsi N, Al-Kindi H, Al-Jardani A, Al-Shukri I, et al.
East Mediterr Health J
. 2025 Feb;
31(1):30-36.
PMID: 39945183
Background: Since the introduction of vaccination in Oman in 1981, measles incidence has decreased, and Oman achieved measles elimination in 2019. Measles cases in the country are currently import-related. Aim:...
2.
Kurubarahalli Patel P, Al-Rawahi B, Al-Farsi N, Al-Mahruqi S, Al-Busaidy A, Al-Abri S, et al.
IJID Reg
. 2025 Jan;
14:100552.
PMID: 39877412
Objectives: The epidemiology of measles in Oman has shown a decreasing trend since the introduction of vaccines with high coverage, even at the district level. Oman achieved elimination status in...
3.
Al-Jardani A, Al-Wahaibi A, Al Rashdi A, Spruijtenburg B, AlBulushi N, Rani R, et al.
J Fungi (Basel)
. 2024 Nov;
10(11).
PMID: 39590715
Mucormycosis is a rare, severe fungal infection mainly affecting immunocompromised individuals. Because of limited data on its epidemiology in Oman, we present this national, multicentric, retrospective review that includes all...
4.
K Patel P, Al-Rawahi B, Al-Farsi N, Al-Mahruqi S, Al-Busaidy A, Al-Abri S
IJID Reg
. 2024 Oct;
13:100437.
PMID: 39376668
Objectives: The main objective of the study is to describe the five lines of evidence of measles and rubella elimination in Oman. Methods: A descriptive record review of the national...
5.
Silva D, Centis R, DAmbrosio L, Mello F, Pereira G, Aguirre S, et al.
J Bras Pneumol
. 2024 Jul;
50(3):e20240077.
PMID: 38985022
No abstract available.
6.
Petersen E, Al-Abri S, Al-Jardani A, Memish Z, Aklillu E, Ntoumi F, et al.
Int J Infect Dis
. 2024 Mar;
141S:107002.
PMID: 38479577
Objectives: To review the evidence that migrants from tuberculosis (TB) high-incidence countries migrating to TB low-incidence countries significantly contribute to active TB cases in the counties of destination, primarily through...
7.
Goletti D, Al-Abri S, Migliori G, Arlehamn C, Haldar P, Sundling C, et al.
Int J Infect Dis
. 2024 Mar;
141S:106993.
PMID: 38458422
No abstract available.
8.
Elgalib A, Lau R, Al-Habsi Z, Shah S, Al-Rawahi B, Al-Abri S
East Mediterr Health J
. 2024 Feb;
30(1):5-6.
PMID: 38415331
No abstract available.
9.
Goletti D, Al-Abri S, Migliori G, Coler R, Ong C, Esposito S, et al.
Int J Infect Dis
. 2023 Dec;
130 Suppl 1:S1-S3.
PMID: 38039194
No abstract available.
10.
Casco N, Jorge A, Palmero D, Alffenaar J, Fox G, Ezz W, et al.
Eur Respir J
. 2023 Oct;
62(5).
PMID: 37827576
Background: Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and...